Clinical Trial Update: Analysis of Response of Subjects With Atopic Dermatitis or Psoriasis to Oral Vitamin D3 [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the effects of oral vitamin D3 (cholecalciferol) in subjects with atopic dermatitis or psoriasis; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis
• Psoriasis

Drugs mentioned

• Vitamin D3 (Cholecalciferol) (Cholecalciferol)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Atopic Dermatitis, Psoriasis | Phase 2 | Status: COMPLETED | Results posted: 2013-01-22